Neural transplantation for treatment of Parkinson's disease

Drug Discovery Today

Volumn 7, Issue 12, 2002, Pages 674-682

  Borlongan, Cesario V ^a   Sanberg, Paul R ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; ALPHA TOCOPHEROL; CASPASE INHIBITOR; CHELATING AGENT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; NEUROIMMUNOPHILIN; NEUROTROPHIC FACTOR; SCAVENGER; SELEGILINE; UNCLASSIFIED DRUG;

ADRENAL CELL; APOPTOSIS; BRAIN TRANSPLANTATION; CELL ENCAPSULATION; CELL IMMORTALIZATION; CELL LINE; CELL TRANSPLANTATION; CELL VIABILITY; CLINICAL TRIAL; DONOR; FETUS CELL; GENE THERAPY; GENETIC ENGINEERING; GRAFT SURVIVAL; HALLUCINATION; HUMAN; KIDNEY CELL; NEPHROTOXICITY; NERVE CELL; NONHUMAN; PARKINSON DISEASE; REVIEW; SERTOLI CELL; STEM CELL; XENOGRAFT; ANIMAL; AUTOTRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; SWINE;

ANIMAL; BRAIN TISSUE TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; GENETIC ENGINEERING; GRAFT SURVIVAL; HUMAN; PARKINSON DISEASE; SWINE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HETEROLOGOUS; ANIMALS; HUMANS;

EID: 0037096220     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02297-3     Document Type: Review

References (60)

1. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease
2. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
3. Transplantation of embryonic dopamine neurons for severe Parkinson's disease
4. Porcine neural xenografts in rats and mice: Donor tissue development and characteristics of rejection
5. Porcine neural xenografts in the immunocompetent rat: Immune response following grafting of expanded neural precursor cells
6. Xenotransplantation for brain repair: Reduction of porcine donor tissue immunogenicity by treatment with anti-Gal antibodies and complement
7. Porcine xenografts in Parkinson's disease and Huntington's disease patients: Preliminary results
8. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease
9. Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pre-transected peripheral nerve. Case report
10. Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promotes long-term functional recovery in hemiparkinsonian rats
11. Purification of adrenal chromaffin cells increases antinociceptive efficacy of xenotransplants without immunosuppression
12. Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation
13. Kidney cografts enhance fiber outgrowth from ventral mesencephalic grafts to the 6-OHDA-lesioned striatum, and improve behavioral recovery
14. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats
15. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex
16. Sertoli cell-enriched fractions in successful islet cell transplantation
17. Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs
18. Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats
19. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain
20. Intrastriatal transplantation of Sertoli cells may improve amphetamine-induced rotation and tyrosine hydroxylase immunoreactivity of the striatum in hemiparkinsonian rats
21. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates
22. Role of basic FGF and oxygen in control of proliferation, survival, and neuronal differentiation in carotid body chromaffin cells
23. Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen
24. Update on immunoisolation cell therapy for CNS diseases
25. Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study
26. Neural transplantation for Parkinson's disease
27. Encapsulated neural transplants
28. Motor fluctuations and dyskinesia in Parkinson's disease
29. Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins
30. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease
31. Neural transplantation of hNT neurons for Huntington's disease
32. Transplantation of cultured human neuronal cells for patients with stroke
33. Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism: A review
34. Prospects for the clinical application of neural transplantation with the use of conditionally immortalized neuroepithelial stem cells
35. Dopaminergic neurons protected from degeneration by GDNF gene therapy
36. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease
37. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts
38. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
39. Neural-targeted gene therapy for rodent and primate hemiparkinsonism
40. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats
41. Cell therapy and transplantation in Parkinson's disease
42. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo
43. Functional recovery in parkinsonian monkeys treated with GDNF
44. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease
45. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release
46. Cyclosporine A-induced hyperactivity in rats: Is it mediated by immunosuppression, neurotrophism, or both?
47. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine
48. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A
49. A novel immunophilin ligand: Distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease
50. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease
51. Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells
52. Fluorescent double-label method to detect and confirm apoptotic nuclei in Parkinson's disease
53. Histochemical detection of apoptosis in Parkinson's disease
54. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
55. An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
56. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity is attenuated in mice overexpressing bcl-2
57. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinium-induced toxicity of cultured fetal rat mesencephalic dopamine neurons
58. Caspase inhibition reduces apoptosis and increases survival of nigral transplants
59. Neuroprotection of grafted neurons with a gdnf/caspase inhibitor cocktail
60. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons